31Jan 2016

Management of cervical lymphadenopathy

  • Department of Surgery, College of Medicine, AL-Iraqia University, Baghdad, Iraq.
  • Abstract
  • Keywords
  • Cite This Article as
  • Corresponding Author

Background: - Cervical lymphadenopathy refers to lymphadenopathy of the cervical lymph nodes (the glands in the neck), the term lymphadenopathy strictly speaking refers to disease of the lymph nodes. Objectives:-To diagnose the causes of the cervical lymphadenopathy and the management of this problem Method: - This is an interventional study on 40 patients with cervical lymphadenopathy from January 2015 to December 2015. Results:- Forty patients were studied, 30 female (75%) and 10 male (25%), and female to male ratio 3:1. The age ranged from 1 to 70 years, with a mean age of 20 years + 5 years. The majority being in the 1st decade of life constituting 10 patients (25%). Also our study showed that the causes of the cervical lymphadenopathy are reactive adenitis 12 patients (30%) followed by acute bacterial suppurative adenitis 10 patients (25%), Hodgkin lymphoma 4 patients (10%), non Hodgkin lymphoma 3 patients (7.5%), chronic non specific adenitis 3 patients (7.5%), secondary metastases 2 patients (5%), tuberculosis adenitis 2 patients (5%), chronic lymphocytic leukaemia 1 patient (2.5%), infectious mononucleosis 1 patient (2.5%), typhoid fever 1 patient (2.5%), and Castleman disease 1 patient (2.5%). Conclusion:- Our study showed that the causes of the cervical lymphadenopathy are reactive adenitis, followed by acute bacterial suppurative adenitis , Hodgkin lymphoma , non Hodgkin lymphoma, chronic non specific adenitis, secondary metastases, tuberculosis adenitis, chronic lymphocytic leukaemia, infectious mononucleosis, typhoid fever , and Castleman disease. In our study we considered the incisional or excisional biopsy with or without Fine-needle aspiration cytology befor it, and it is the best diagnostic methods to diagnose the pathology of the lymphadenopathy, and all patients are treated according to his or her condition and there was no death rate during our study.


[Luai Farhan Zghair (2016); Management of cervical lymphadenopathy Int. J. of Adv. Res. 4 (Jan). 1164-1170] (ISSN 2320-5407). www.journalijar.com


Luai Farhan Zghair